Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 3 days agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
FOX21 Colorado Springs· 5 days agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 5 days agoNorthampton, MA, May 9, 2024 – Seven scientists supported by the American Macular Degeneration Foundation (AMDF) and studying age-related macular ...
Clearside Biomedical stock target cut, maintains Buy rating By Investing.com
Investing.com· 11 hours agoOn Monday, Clearside Biomedical (NASDAQ:CLSD) saw its price target adjusted by H.C. Wainwright. The...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 3 days agoIts flagship product, ADVM-022 (Ixo-vec), aims to revolutionize care for patients with wet age-related macular degeneration (AMD) by ...
EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
GuruFocus.com via Yahoo Finance· 3 days agoThe company utilizes its proprietary Durasert E and Verisome technology platforms to develop...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 4 days agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for < ...
The most innovative Mother’s Day campaigns from Dove, MoneyGram, DoorDash & more
The Drum· 3 days agoFrom heartwarming reunions facilitated by DoorDash to MullenLowe planting career opportunities for...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives $46.43 Average Target Price from Analysts
ETF DAILY NEWS· 3 days agoShares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat ...